Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

795.67 -0.61 (-0.08%)
Official Closing Price Updated: 5:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,165,930
Open 791.37
Bid (Size) 792.30 (1)
Ask (Size) 795.50 (1)
Prev. Close 796.28
Today's Range 787.10 - 797.75
52wk Range 567.64 - 972.53
Shares Outstanding N/A
Dividend Yield 0.65%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Eli Lilly an Undervalued Growth Stock to Buy Now?
Via The Motley Fool
1 Spectacular Growth Stock That Could Join Nvidia, Tesla, Apple, and Others in the $1 Trillion Club
Via The Motley Fool

Performance

YTD
+34.36%
+34.36%
1 Month
+5.39%
+5.39%
3 Month
-13.94%
-13.94%
6 Month
-11.72%
-11.72%
1 Year
+39.43%
+39.43%

More News

Read More
Are You Ready To Trade Biotech Stocks At The Cusp Of A Bear Market?
Via Talk Markets
Topics ETFs Stocks / Equities
Eli Lilly Stock Is Rising Monday: What's Going On?
Via Benzinga
Exposures Product Safety
3 Big-Name Stocks Just Announced Big-Time Dividend Increases
Via MarketBeat
Topics ETFs
Better Buy: Eli Lilly or Novo Nordisk?
Via The Motley Fool
Does This News From the FDA Make Eli Lilly a Buy for 2025?
Via The Motley Fool
Exposures Product Safety
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Via Benzinga
Is Merck the Next Big Weight-Loss Stock?
Via The Motley Fool
3 Stocks That Could Join the Trillion-Dollar Market Cap Club Next Year
Via The Motley Fool
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
Via Benzinga
Exposures Product Safety
2 Dividend-Growth Stocks That Billionaire Izzy Englander Loves
Via The Motley Fool
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
Via The Motley Fool
Why Viking Therapeutics Tumbled by More Than 10% This Week
Via The Motley Fool
Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?
Via Investor's Business Daily
Exposures Product Safety
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up
Via The Motley Fool
Stock Market Tumbles, Treasury Yields Soar On Fed Rate Outlook: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss
Via Benzinga
Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.
Via Investor's Business Daily
Novo Nordisk's Hybrid Weight Loss Drug Falls Short On Expectations, Stock Plunges
Via Benzinga
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Via Benzinga
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List
Via Investor's Business Daily
Exposures Product Safety
These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?
Via The Motley Fool
This Is Huge News for Eli Lilly Investors
Via The Motley Fool
Who's Next To Join Tesla, Broadcom In $1 Trillion Club? Over 50% Say The World's Biggest Retailer
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.